What we do
We do high quality genetics testing for a global clinical community. By combining a state of the art laboratory process, the latest sequencing technology, AI empowered data-crunching tools and techniques, world-class professionals and a holistic customer experience approach, we are leading the way of changing mainstream healthcare of tomorrow.
We provide clinicians, and their patients, with comprehensive and high-quality tools and resources for diagnostics of genetic conditions. In doing so, we provide possibilities for targeted treatment and individualized care for patients.
Chief Executive Officer
Laboratory Director, Chief Medical Officer, MD, Ph.D.
President, Chief Medical Officer, MD, Ph.D.
A Finnish study finds evidence indicating the JPH2 gene to be causative in hypertrophic cardiomyopathy
Published on September 21, 2018
This study1 provides the first substantial evidence of the JPH2 gene associating with monogenic familial hypertrophic cardiomyopathy (HCM). The study ‘Heterozygous Junctophilin-2 (JPH2) p.(Thr161Lys) is a monogenic cause for HCM with heart failure’ was published recently in PLOS ONE. Hypertrophic cardiomyopathy is considered the most common form of inherited cardiomyopathies,…Read more
See all news
Ajurinkatu 16, Kuopio, Finland
Annual Pediatric Association organises an educational days for paediatrician and those who has specialised on the paediatric diseases. The educational paediatric days will be held in Kuopio from 7th to 8th November. We will be attending this event and welcome you to visit us at our booth to discuss the…Read more
See all events